{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T05:35:19Z","timestamp":1769924119930,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T00:00:00Z","timestamp":1577404800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ahj.2019.12.006","type":"journal-article","created":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T20:15:12Z","timestamp":1576613712000},"page":"64-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Cryoballoon catheter ablation versus antiarrhythmic drugs as a first-line therapy for patients with paroxysmal atrial fibrillation: Rationale and design of the international Cryo-FIRST study"],"prefix":"10.1016","volume":"222","author":[{"given":"Jean Sylvain","family":"Hermida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saverio","family":"Iacopino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Arena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikola","family":"Pavlovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vedran","family":"Velagic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stewart","family":"Healey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas L.","family":"Packer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz-Friedrich","family":"Pitschner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"de Asmundis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malte","family":"Kuniss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian Battista","family":"Chierchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2019.12.006_bb0005","doi-asserted-by":"crossref","unstructured":"Kirchhof P, Benussi S, Kotecha D, et al. ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace 2016; 18(11): 1609\u20131678.","DOI":"10.1093\/europace\/euw295"},{"key":"10.1016\/j.ahj.2019.12.006_bb0010","doi-asserted-by":"crossref","unstructured":"Calkins H, Hindricks G, Cappato R, et al. HRS\/EHRA\/ECAS\/ APHRS\/SOLAECE Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation. Heart Rhythm 2017; doi: https:\/\/doi.org\/10.1016\/j.hrthm.2017.05.012. [Epub ahead of print]","DOI":"10.1016\/j.hrthm.2017.05.012"},{"issue":"8","key":"10.1016\/j.ahj.2019.12.006_bb0015","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ahj.2019.12.006_bb0020","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.amjcard.2013.05.063","article-title":"Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population","volume":"112","author":"Colilla","year":"2013","journal-title":"Am J Cardiol"},{"issue":"11","key":"10.1016\/j.ahj.2019.12.006_bb0025","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrcardio.2014.118","article-title":"Global epidemiology of atrial fibrillation","volume":"11","author":"Rahman","year":"2014","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"10.1016\/j.ahj.2019.12.006_bb0030","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1161\/01.CIR.93.6.1262","article-title":"Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association","volume":"93","author":"Prystowsky","year":"1996","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ahj.2019.12.006_bb0035","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1540-8159.2000.tb00794.x","article-title":"Silent atrial fibrillation--another Pandora's box","volume":"23","author":"Savelieva","year":"2000","journal-title":"Pacing Clin Electrophysiol"},{"issue":"8","key":"10.1016\/j.ahj.2019.12.006_bb0040","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1540-8167.2012.02381.x","article-title":"Venice Chart international consensus document on atrial fibrillation ablation: 2011 update","volume":"23","author":"Raviele","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"4","key":"10.1016\/j.ahj.2019.12.006_bb0045","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/CIR.0000000000000366","article-title":"Benjamin EJ, Go AS, et al. American Heart Association Statistics Committee; Stroke Statistics Subcommittee. Executive Summary: Heart Disease and Stroke Statistics--2016 Update: A Report From the American Heart Association","volume":"133","author":"Mozaffarian D","year":"2016","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ahj.2019.12.006_bb0050","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.hrthm.2013.05.013","article-title":"Increasing time between first diagnosis of atrial fibrillation and catheter ablation adversely affects long-term outcomes","volume":"10","author":"Bunch","year":"2013","journal-title":"Heart Rhythm"},{"issue":"21","key":"10.1016\/j.ahj.2019.12.006_bb0055","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1001\/jama.293.21.2634","article-title":"Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial","volume":"293","author":"Wazni","year":"2005","journal-title":"JAMA"},{"issue":"17","key":"10.1016\/j.ahj.2019.12.006_bb0060","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1056\/NEJMoa1113566","article-title":"Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation","volume":"367","author":"Cosedis Nielsen","year":"2012","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ahj.2019.12.006_bb0065","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1001\/jama.2014.467","article-title":"RAAFT-2 Investigators. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial","volume":"311","author":"Morillo","year":"2014","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ahj.2019.12.006_bb0070","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/europace\/euu376","article-title":"Radiofrequency ablation vs. antiarrhythmic drug therapy as first line treatment of symptomatic atrial fibrillation: systematic review and meta-analysis","volume":"17","author":"Hakalahti","year":"2015","journal-title":"Europace"},{"issue":"23","key":"10.1016\/j.ahj.2019.12.006_bb0075","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa1602014","article-title":"Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation","volume":"374","author":"Kuck","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ahj.2019.12.006_bb0080","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/europace\/eur299","article-title":"Isolating the pulmonary veins as first-line therapy in patients with lone paroxysmal atrial fibrillation using the cryoballoon","volume":"14","author":"Namdar","year":"2012","journal-title":"Europace"},{"issue":"8","key":"10.1016\/j.ahj.2019.12.006_bb0085","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jacc.2009.11.040","article-title":"Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis","volume":"55","author":"de Vos","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2019.12.006_bb0090","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ahj.2004.09.053","article-title":"Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation","volume":"149","author":"Kerr","year":"2005","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.ahj.2019.12.006_bb0095","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10840-015-0041-1","article-title":"The impact of cryoballoon-based catheter ablation on left atrial structural and potential electrical remodeling in patients with paroxysmal atrial fibrillation","volume":"44","author":"Canpolat","year":"2015","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.ahj.2019.12.006_bb0100","doi-asserted-by":"crossref","unstructured":"Packer DL, Mark DB, Robb RA, et al. CABANA Investigators. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial. JAMA. 2019. doi: https:\/\/doi.org\/10.1001\/jama.2019.0693. [Epub ahead of print]","DOI":"10.1001\/jama.2019.0693"},{"issue":"16","key":"10.1016\/j.ahj.2019.12.006_bb0105","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.jacc.2012.11.064","article-title":"Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial","volume":"61","author":"Packer","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"38","key":"10.1016\/j.ahj.2019.12.006_bb0110","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/eurheartj\/ehw285","article-title":"Brugada J; FIRE AND ICE Investigators. Cryoballoon or radiofrequency ablation for symptomatic paroxysmal atrial fibrillation: reintervention, rehospitalization, and quality-of-life outcomes in the FIRE AND ICE trial","volume":"37","author":"Kuck","year":"2016","journal-title":"Eur Heart J"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870319303461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870319303461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:03:36Z","timestamp":1757570616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870319303461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":22,"alternative-id":["S0002870319303461"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2019.12.006","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cryoballoon catheter ablation versus antiarrhythmic drugs as a first-line therapy for patients with paroxysmal atrial fibrillation: Rationale and design of the international Cryo-FIRST study","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2019.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}